{"name":"Hologic","slug":"hologic","ticker":"HOLX","exchange":"NASDAQ","domain":"hologic.com","description":"Hologic, Inc. is an American medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging.","hq":"Marlborough, MA, USA","founded":0,"employees":"7070","ceo":"Stephen P. MacMillan","sector":"Women\\","stockPrice":76.01,"stockChange":0,"stockChangePercent":0,"marketCap":"$17.0B","metrics":{"revenue":4126500096,"revenueGrowth":2.5,"grossMargin":60.4,"rdSpend":248200000,"netIncome":565700000,"cash":2366599936,"dividendYield":0,"peRatio":31.5,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"Aptima HPV patent cliff ($100M at risk)","drug":"Aptima HPV","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"earnings","headline":"Hologic Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Hologic reported fourth quarter and full year 2023 financial results, with revenue of $1.04 billion and adjusted EPS of $1.45.","drugName":"","sentiment":"positive"},{"date":"2023-09-28","type":"deal","headline":"Hologic to Acquire Biotheranostics for $230 Million","summary":"Hologic announced the acquisition of Biotheranostics, a developer of molecular diagnostic tests for cancer, for $230 million.","drugName":"","sentiment":"positive"},{"date":"2023-06-29","type":"regulatory","headline":"FDA Approves Hologic's Genius 3D Mammography System","summary":"The FDA approved Hologic's Genius 3D Mammography system, a digital breast tomosynthesis (DBT) system for breast cancer screening.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxPcGUxSVhmdWF4amVHZTlFYkdqV2xRUENBaFptUENMQWh1UlVjTDl1aWp0cEx4M0p0Sm5rNmM4endHY0VzMFNLUEoxZFQ1Uk8xeXEwa1lxOXppY3JPQmhTak5pN1FLc1RnNWxoVnhEZUx0aTBjdXVQYlRzX2JwZ3ctZy1TVE1wbGY4UlFWMm8wOUgxNzJueWVtendqUVN1SzBoQlFUWTYzMm1xNzNXMzZVSERmZkttRW9FcXpXMVJnd050VU04WGllLXVNWW96bnJid1ZIcmJMNHlhUkctTDF1MWg0eTZrYVc0WHcyLVprZmY3Q09QX0NzcnRLQ0E0WWdQV2RTRlNYX1RBYXNNczBjb1l3?oc=5","date":"2026-04-07","type":"earnings","source":"StockStory","summary":"A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks’ Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack - StockStory","headline":"A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks’ Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOeDBMcVNleUxvX2JfNTV0WDJQM1NranFxMmotcGlacmZEV0swNFY1WHBTM3NwX2hCY3B2d2dzUUduNHJqNUFLVzlpUElMUjJ3R2oxVVZWMXk1SHkwQWtUOVRxYXNrYjVxYkNpdHRTcnJEVm50VVVzQnZDSFV4d1RCck0yYWIxOGZPLTRNV1BURXVMTkxNTlJxNTVmNTNZdw?oc=5","date":"2026-04-07","type":"pipeline","source":"Stock Titan","summary":"Blackstone and TPG take Hologic private, name Joe Almeida CEO - Stock Titan","headline":"Blackstone and TPG take Hologic private, name Joe Almeida CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOeHk3aHVFYnZXdE1uVnRVdnBOaU9CMHgxZ2RpaEFELWdvU29KR242U2hOcnJvX1V2MlowcC03U1hyX3lLNkVBa2wtcFo1a0VfRW9nZkpiSENhcjVSeDhpNlJ1dWdWcGlQT0psV1JhbzhqaUdFbEVmaUEzbUwzOGd1dTVrLWp4WmdUR0RnOUFLVWdXeGgtVEE?oc=5","date":"2026-04-07","type":"pipeline","source":"Stock Titan","summary":"Hologic (NASDAQ: HOLX) notifies Nasdaq of listing withdrawal - Stock Titan","headline":"Hologic (NASDAQ: HOLX) notifies Nasdaq of listing withdrawal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE5kaWJzLTRLdk9IOV90TkdXZHgwSUFsNlMyRWNxN0RNTXo5XzR0ajVQNWR2cjNWbVJNSW8xUF9Ub3dadmJmUE82S0NmZUp6UkN3Ry1ET05VdTAzbFJGYkHSAWNBVV95cUxOT2p4R2NaaEU2TzFtLTdBVUJOY2dVZ3luWDFLcmZFZU5NT0FqamxzNlFFN2hCMHRlbHN5YmhqM21JUmgyUm1qYXU4eS1sWF9xdWIzWk5BcnBqVUoxanYtblZOZnM?oc=5","date":"2026-03-24","type":"pipeline","source":"Bitget","summary":"HOLX or ALGN: Which Medical Technology Stock Should You Choose for Investment Right Now? - Bitget","headline":"HOLX or ALGN: Which Medical Technology Stock Should You Choose for Investment Right Now?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxOR0N1Y1FTY0gyRU85Z3ZoN3pyRVdLWDFRT2VPX2cyQzJWTEl5RGRmdlFhbEZ4OW9US2Zyd3pWWUg0M0puemZYX0psamhMREFOOVBHTlpyQmlabVhLQTd3bmY3WGhmNkgxYkFuNVhfSFpBUGRERDJWWml4em53ZFhBWWJkdy1CcUw3YUU5S2hwVEZvdDN2YnMxbFJhUHhMOWdaNk5WamEwR3VtOC1XVk5CREpCd3o0aUxiUkdCSXl4VWE2V0JESldsUWJRVHZsaEF2a2hjU0tNLXBacXhNTTcxSV9iNjVWZVlVb1RUcmk1R2o1S2lTS3lVaHJhZ0ZFVkRZUnlSRU1lRS1XejNzWWc?oc=5","date":"2026-01-07","type":"pipeline","source":"PR Newswire","summary":"Hologic Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hologic, Inc. - HOLX - PR Newswire","headline":"Hologic Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hologic, I","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOd1Q5YTRYUm9haDNvbVNyVU55dzhaS2Z0enM3X2Njd0ZwanBWb1hkWHZScUg5SWhwdVhGT2hRUENrTWlndXdaRmRNaTRfX0gwTm5EdldpVUg4NktYX1VhZ2FrcEd6UFY3RzJwVTM3VkZjU3J5SnU1a3Y1RjlnbkxjSzVENmVMSkVRX0ZmRlNfMFduODZvMDFfQ01SNkNPWUpNeXptX2xUZ2UwdThZbEVESGZ3?oc=5","date":"2025-12-24","type":"pipeline","source":"Seeking Alpha","summary":"Hologic says 2026 CVR is more challenging with stopped shipment of product (HOLX:NASDAQ) - Seeking Alpha","headline":"Hologic says 2026 CVR is more challenging with stopped shipment of product (HOLX:NASDAQ)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxPUVhpaE93cmlUY0RNVXVaZmtQQmtYdlVpMV9WNVFnQmIzWnAtWXdnVjhoYmk0SUVJZVFyVmpHNnVDUWdEbFdpVElEbW94VUFyTnNTSVcwYS0wQ0VqTEtmNHZQUDFIeHk0M0FEbk1UdWIxX1B0NHNhdXlxSk56ZUZIUm1DZWFOYnM0U09uajFzZ0RTNXpVY01hX3ZZX3dDdFNDUU81SFZ4QWZpUzRfUklDZzVLUjZ3TWl6d2tWYThZdHhZM0Rzdm1KSTJSd0lDd3FG?oc=5","date":"2025-12-15","type":"pipeline","source":"The Globe and Mail","summary":"1 S&P 500 Stock Worth Your Attention and 2 We Avoid - The Globe and Mail","headline":"1 S&P 500 Stock Worth Your Attention and 2 We Avoid","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxObWVTS1pIaldFVi1LYUo2ZWZ0OS1TSkZaXzFLLV9TZmRNblduaXh4eVRFcjQzQzVadkZXMkJTR0JrdHhLZjJxTXFPS1UzaDVITnBGQ1Y2cEJ2bkJoNlRNWGs1cGlLeWVqVWhkV3J1blVDemZRY05zTmwtVlBNcDRkSGVUSDdPTUE5bzJ6ZTVEeFdVYk5HZ3Y5SUVWY0VQVzlDSmVnMC1GS2stNVRHWmVKdDFUQ01FZy10Mm5vX2Q4NUQ?oc=5","date":"2025-10-30","type":"pipeline","source":"TradingView","summary":"HOLX vs. ABT: Which Medical Technology Stock Is the Better Investment? - TradingView","headline":"HOLX vs. ABT: Which Medical Technology Stock Is the Better Investment?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxQOHFxeGNTaTRiSjFKUDdnTWpfODU1T0RxN1VVLWsyRklNa3lhZ2lUa2Qza24wamxTaHBjZkpOa2otR3RjMGdGRURIUDVoU0g0QkRZY3RkZTRGWjN5b0RjMmJFa0VpaWFNSjBWWEF5T19Ja3VZZnlnakd1TEk0QjJQcFFqZ296UUVGQW9YR1ZTVGtVVHJVRDFKZUVCaTM1NGlLWkpOTE1IakJjZTdINWNxbWJuMVhkbVFIODU5VllWT1BZbGIxT3F3M2ZjcWNuR29DcEhPbkx0VTlMZWdSaTc0RnhRYzAxSW5zMUJ1MXNHTVFNVkJL?oc=5","date":"2025-10-22","type":"deal","source":"proactiveinvestors.com","summary":"Inside Biotech: Blackstone and TPG make $18.3 billion bet on women’s health with Hologic deal - proactiveinvestors.com","headline":"Inside Biotech: Blackstone and TPG make $18.3 billion bet on women’s health with Hologic deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOZm1BeG5fQzZQQWpnZ3Z4NHlfZF93MUdzcU56V0ZJOUJjc1FXRzdFS1RGcVFmVFE0cEx0UlFnSGhyVXYxQUFtRzMwUm1VdW1yN2RrUEtITFFhU09VUXJGbXIzbnFhS3ZVWFVGNXhXUDB0amMwOUp5bTRQUGRjOGJaVmlIZGg3ZXhQLVF3ajYtTWNxUW1YekloVDN6RkszM3VuWkZFQWlaSlZMVGJDeTZSd0xSNGNEcVNDa0RDNlcxYVNRTzF0M2c?oc=5","date":"2025-10-21","type":"pipeline","source":"Reuters","summary":"Blackstone, TPG to take medtech Hologic private for $18.3 billion - Reuters","headline":"Blackstone, TPG to take medtech Hologic private for $18.3 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPdVVRSGlHOHlSSDlSaXV6WXVkQWVIWThLaVE2RXpTLVNWVmlTazZEUlpLMlpVNHN3UW1odHVPVngxVFcwM2lMVktJVURIa3lnNklZNkkzbWhJeXl0MGJwZm5zcFNxNG1MaFBZTEFlNE9rY3RFY1RDWE91NlN2OWU3dFVjMzVjY09wZ0t4SEVySFhKTEZEenoxUFdvZlM1LWNlX2c?oc=5","date":"2025-10-21","type":"deal","source":"The Business Journals","summary":"Hologic to be acquired by Blackstone and TPG in $18.3 billion deal - The Business Journals","headline":"Hologic to be acquired by Blackstone and TPG in $18.3 billion deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNR0lOLUhKUldERmpDSV9JODRBRHotcmU4NEhFaGRHYXFFUExxdnFsdUVxbzVnTm1hZmhoaGM4Mm1MRVVsRl94MmFMWXhNNlR6X0hYWnZZLVUteGFJTm56UkI0dUdReTJLTmNnVlFxWmRCN2lnNjN3dk82NGRSaGxsYTlTckxWdkVBM2FidQ?oc=5","date":"2025-09-24","type":"pipeline","source":"Yahoo Finance","summary":"HOLX to Discontinue Fluoroscan InSight FD Soon: Will the Stock Suffer? - Yahoo Finance","headline":"HOLX to Discontinue Fluoroscan InSight FD Soon: Will the Stock Suffer?","sentiment":"neutral"}],"patents":[{"drugName":"Aptima HPV","drugSlug":"human-papillomavirus","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":100000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Siemens Healthineers","Philips Healthcare","GE Healthcare"],"therapeuticFocus":["Women's Health","Breast Health","Cervical Cancer Screening"],"financials":{"source":"sec_edgar+yahoo","revenue":4100500000,"revenuePeriod":"2025-09-27","revenueHistory":[{"value":4100500000,"period":"2025-09-27"},{"value":4030300000,"period":"2024-09-28"},{"value":4030300000,"period":"2024-09-28"},{"value":4030400000,"period":"2023-09-30"},{"value":4030400000,"period":"2023-09-30"}],"grossProfit":2117900000,"grossProfitHistory":[{"period":"2025-09-30","value":2117900000},{"period":"2024-09-30","value":2227800000},{"period":"2023-09-30","value":2071500000},{"period":"2022-09-30","value":2997400000}],"rdSpend":248200000,"rdSpendHistory":[{"period":"2025-09-30","value":248200000},{"period":"2024-09-30","value":272800000},{"period":"2023-09-30","value":294300000},{"period":"2022-09-30","value":283400000}],"sgaSpend":1069900000,"operatingIncome":785400000,"operatingIncomeHistory":[{"period":"2025-09-30","value":785400000},{"period":"2024-09-30","value":931000000},{"period":"2023-09-30","value":761500000},{"period":"2022-09-30","value":1630800000}],"netIncome":565700000,"netIncomeHistory":[{"period":"2025-09-30","value":565700000},{"period":"2024-09-30","value":789500000},{"period":"2023-09-30","value":456000000},{"period":"2022-09-30","value":1302000000}],"eps":2.49,"epsHistory":[{"period":"2025-09-30","value":2.49},{"period":"2024-09-30","value":3.32},{"period":"2023-09-30","value":1.83},{"period":"2022-09-30","value":5.13}],"cash":1959500000,"cashHistory":[{"period":"2025-09-30","value":1959500000},{"period":"2024-09-30","value":2160200000},{"period":"2023-09-30","value":2722500000},{"period":"2022-09-30","value":2339500000}],"totalAssets":9014900000,"totalLiabilities":3967000000,"totalDebt":2626800000,"equity":5047900000,"operatingCashflow":1057100000,"operatingCashflowHistory":[{"period":"2025-09-30","value":1057100000},{"period":"2024-09-30","value":1285200000},{"period":"2023-09-30","value":1051200000},{"period":"2022-09-30","value":2125700000}],"capex":-152400000,"capexHistory":[{"period":"2025-09-30","value":-152400000},{"period":"2024-09-30","value":-140200000},{"period":"2023-09-30","value":-150200000},{"period":"2022-09-30","value":-127200000}],"freeCashflow":904700000,"dividendsPaid":null,"buybacks":-752900000,"employees":7070,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":282700000,"ebit":257300000,"ebitda":326900000,"period":"2025-12-31","revenue":1047800000,"epsBasic":0.8,"netIncome":179100000,"rdExpense":60500000,"epsDiluted":0.79,"grossProfit":586400000,"operatingIncome":240900000},{"sga":262600000,"ebit":255800000,"ebitda":335300000,"period":"2025-09-30","revenue":1049600000,"epsBasic":0.84,"netIncome":187200000,"rdExpense":65100000,"epsDiluted":0.83,"grossProfit":583500000,"operatingIncome":252900000},{"sga":251300000,"ebit":263900000,"ebitda":334000000,"period":"2025-06-30","revenue":1023800000,"epsBasic":0.87,"netIncome":194900000,"rdExpense":61400000,"epsDiluted":0.86,"grossProfit":576600000,"operatingIncome":260900000},{"sga":274100000,"ebit":600000,"ebitda":76800000,"period":"2025-03-31","revenue":1005300000,"epsBasic":-0.08,"netIncome":-17400000,"rdExpense":61500000,"epsDiluted":-0.08,"grossProfit":377300000,"operatingIncome":37900000},{"sga":281800000,"ebit":278000000,"ebitda":352000000,"period":"2024-12-31","revenue":1021800000,"epsBasic":0.87,"netIncome":201000000,"rdExpense":60300000,"epsDiluted":0.87,"grossProfit":580500000,"operatingIncome":233700000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":76.01,"previousClose":0,"fiftyTwoWeekHigh":76.07,"fiftyTwoWeekLow":51.9,"fiftyTwoWeekRange":"","fiftyDayAverage":75.31,"twoHundredDayAverage":71.65,"beta":0.7,"enterpriseValue":17122545664,"forwardPE":15.7,"priceToBook":3.23,"priceToSales":4.11,"enterpriseToRevenue":4.15,"enterpriseToEbitda":12.68,"pegRatio":1.66,"ebitda":1350700032,"ebitdaMargin":32.7,"freeCashflow":848612480,"operatingCashflow":1097699968,"totalDebt":2520300032,"debtToEquity":48.1,"currentRatio":4.04,"returnOnAssets":7.4,"returnOnEquity":10.9,"analystRating":"","recommendationKey":"hold","numberOfAnalysts":9,"targetMeanPrice":76.67,"targetHighPrice":78,"targetLowPrice":76,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":0.8,"institutionHeldPercent":96.5,"sharesOutstanding":223244905,"floatShares":221206679,"sharesShort":7100246,"shortRatio":2.78,"shortPercentOfFloat":3.2,"epsTrailing":2.41,"epsForward":0,"revenuePerShare":18.37,"bookValue":23.51,"officers":[{"age":null,"name":"Mr. Paul  Malenchini","title":"Chief Information Officer"},{"age":null,"name":"Mr. Michael J. Watts","title":"Corporate Vice President of Investor Relations"},{"age":49,"name":"Ms. Anne M. Liddy","title":"General Counsel"},{"age":70,"name":"Ms. Diana  De Walt SPHR","title":"Senior Vice President of Global Human Resources"},{"age":null,"name":"Ms. Monica Aguirre Berthelot","title":"VP & Chief of Staff"},{"age":null,"name":"Mr. Scott  Christensen","title":"Senior Vice President of Global Supply Chain & Regulatory Affairs"},{"age":40,"name":"Mr. Brandon  Schnittker","title":"President of GYN Surgical Solutions"},{"age":62,"name":"Mr. Mark  Horvath","title":"President of Breast & Skeletal Health Solutions"}],"industry":"Medical Instruments & Supplies","irWebsite":"http://investors.hologic.com/","website":"https://www.hologic.com","phone":"508 263 2900"}}